[1]
2024. Effect of DOPA decarboxylase inhibitor supplements on the incidence of urinary tract infections in Parkinson’s disease patients: A systematic review and meta-analysis of randomized controlled trials. Archivio Italiano di Urologia e Andrologia. 96, 4 (Oct. 2024). DOI:https://doi.org/10.4081/aiua.2024.12833.